Global Information
회사소개 | 문의 | 비교리스트

세계의 단백질 발현 시장 예측(2019-2028년)

Global Protein Expression Market Forecast 2019-2028

리서치사 Inkwood Research
발행일 2020년 06월 상품 코드 940526
페이지 정보 영문 179 Pages
가격
US $ 2,500 ₩ 2,815,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 되지 않으며, 인쇄 또한 불가능합니다.
US $ 3,000 ₩ 3,378,000 PDF (Multi User License) help
동일 사업장(소재지) 내 5명까지 이용가능한 라이센스입니다. PDF 파일은 Copy & Paste가 되지 않습니다. 인쇄는 1명당 1회에 한해 가능하며 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,500 ₩ 5,068,000 PDF (Enterprisewide License) help
동일 기업 및 100% 자회사의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수 제한은 없습니다. PDF 파일은 Copy & Paste 가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.

주의 : 라이선스에 따라 자료 이용 및 인쇄 등에 제약이 있을 수 있습니다. 자세한 내용은 라이선스 설명문( )을 참고하여 주시기 바랍니다.



세계의 단백질 발현 시장 예측(2019-2028년) Global Protein Expression Market Forecast 2019-2028
발행일 : 2020년 06월 페이지 정보 : 영문 179 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 단백질 발현 시장은 2019-2028년간 10.99%의 연평균 복합 성장률(CAGR)로 성장할 전망입니다. 시장 성장 주요인은 세계적인 의료비 지출 증가, 만성질환 증가, 단백질체학 및 유전체학 분야에서의 연구개발 증가 등입니다.

세계의 단백질 발현(Protein Expression) 시장에 대해 조사했으며, 시장 규모, 시장 성장 촉진요인 및 억제요인, 제품 종류·용도·최종사용자·지역별 시장 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 전해드립니다.

목차

제1장 조사 범위와 조사 방법

  • 조사 목적
  • 조사 범위
  • 조사 방법
  • 전제조건 및 제한

제2장 개요

  • 시장 규모 추정
  • 시장 개요

제3장 시장 역학

  • 시장의 정의
  • 주요 성장 촉진요인
    • 만성질환 증가
    • 세계적인 의료비 지출 증가
    • 유전체학 및 단백질체학 분야에서의 연구개발 증가
  • 주요 성장 억제요인
    • 단백질 발현 시스템의 높은 비용
    • 번역후 수식을 위한 효과적인 시스템 부족

제4장 주요 분석

  • 주요 투자 인사이트
  • Porter's Five Forces 분석
  • 기회 매트릭스
  • 벤더 상황

제5장 시장 분석 : 제품 유형별

  • 시약
  • 발현 벡터
  • 수용성 세포(COMPETENT CELLS)
  • 기기
  • 서비스

제6장 시장 분석 : 용도별

  • 치료
  • 산업
  • 연구

제7장 시장 분석 : 최종사용자별

  • 제약기업 및 바이오 기업
  • 학술조사기관
  • 계약 연구 조직
  • 기타

제8장 시장 분석 : 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역
    • 라틴아메리카
    • 중동 및 아프리카

제9장 기업 개요

  • AGILENT TECHNOLOGIES INC
  • BECTON, DICKINSON AND COMPANY
  • BIO-RAD LABORATORIES INC
  • GENSCRIPT BIOTECH CORPORATION
  • LIFESENSORS INC
  • MERCK KGAA
  • PROMEGA CORPORATION
  • QIAGEN NV
  • TAKARA HOLDINGS INC
  • THERMO FISHER SCIENTIFIC INC
  • LONZA INC
  • NEW ENGLAND BIOLABS
  • BIOTECHRABBIT GMBH
  • PROMAB BIOTECHNOLOGIES GMBH
  • PEAK PROTEINS LTD
LSH 20.06.24

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - PROTEIN EXPRESSION
  • TABLE 2: GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: GLOBAL PROTEIN EXPRESSION MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL REAGENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: GLOBAL REAGENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL EXPRESSION VECTORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: GLOBAL EXPRESSION VECTORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL COMPETENT CELLS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: GLOBAL COMPETENT CELLS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 11: GLOBAL INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL SERVICES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 13: GLOBAL SERVICES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 15: GLOBAL PROTEIN EXPRESSION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL THERAPEUTIC MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 17: GLOBAL THERAPEUTIC MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL INDUSTRIAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 19: GLOBAL INDUSTRIAL MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 21: GLOBAL RESEARCH MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL PROTEIN EXPRESSION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 23: GLOBAL PROTEIN EXPRESSION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 25: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 27: GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 29: GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 31: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL PROTEIN EXPRESSION MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 33: GLOBAL PROTEIN EXPRESSION MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 34: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 35: NORTH AMERICA PROTEIN EXPRESSION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 36: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 37: EUROPE PROTEIN EXPRESSION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 38: ASIA PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 39: ASIA PACIFIC PROTEIN EXPRESSION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 40: REST OF WORLD PROTEIN EXPRESSION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 41: REST OF WORLD PROTEIN EXPRESSION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: KEY INVESTMENT INSIGHTS
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: GLOBAL PROTEIN EXPRESSION MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2019
  • FIGURE 6: GLOBAL PROTEIN EXPRESSION MARKET, BY REAGENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 7: GLOBAL PROTEIN EXPRESSION MARKET, BY EXPRESSION VECTORS, 2019-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL PROTEIN EXPRESSION MARKET, BY COMPETENT CELLS, 2019-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL PROTEIN EXPRESSION MARKET, BY INSTRUMENTS, 2019-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL PROTEIN EXPRESSION MARKET, BY SERVICES, 2019-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL PROTEIN EXPRESSION MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2019
  • FIGURE 12: GLOBAL PROTEIN EXPRESSION MARKET, BY THERAPEUTIC, 2019-2028 (IN $ MILLION)
  • FIGURE 13: GLOBAL PROTEIN EXPRESSION MARKET, BY INDUSTRIAL, 2019-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL PROTEIN EXPRESSION MARKET, BY RESEARCH, 2019-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL PROTEIN EXPRESSION MARKET, GROWTH POTENTIAL, BY END-USER, IN 2019
  • FIGURE 16: GLOBAL PROTEIN EXPRESSION MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL PROTEIN EXPRESSION MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2019-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL PROTEIN EXPRESSION MARKET, BY CONTRACT RESEARCH ORGANIZATIONS, 2019-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL PROTEIN EXPRESSION MARKET, BY OTHER END-USERS, 2019-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 21: UNITED STATES PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 22: CANADA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 23: EUROPE PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 24: UNITED KINGDOM PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 25: GERMANY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 26: FRANCE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 27: ITALY PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 28: RUSSIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 29: BELGIUM PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 30: POLAND PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 31: REST OF EUROPE PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 32: ASIA PACIFIC PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 33: CHINA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 34: JAPAN PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 35: INDIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 36: SOUTH KOREA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 37: INDONESIA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 38: THAILAND PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 39: VIETNAM PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 40: AUSTRALIA & NEW ZEALAND PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 41: REST OF ASIA PACIFIC PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 42: REST OF WORLD PROTEIN EXPRESSION MARKET, REGIONAL OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 43: LATIN AMERICA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 44: MIDDLE EAST & AFRICA PROTEIN EXPRESSION MARKET, 2019-2028 (IN $ MILLION)

KEY FINDINGS

The global protein expression market is set to garner a CAGR of 10.99% during the forecast period, 2019-2028. The rising healthcare expenditure across the globe, the growing number of chronic diseases, and increasing R&D in the field of proteomics and genomics, are among the eminent factors propelling the market growth.

MARKET INSIGHTS

Protein expression is a biotechnological procedure that entails the generation of precise proteins. There is an increasing prevalence of chronic diseases across the world, which is expected to surge further by 2020 from that of 2001. Of these chronic diseases, cardiovascular diseases make up for more than half of the chronic diseases, with diabetes registering fast-paced growth. Protein expression systems are utilized in therapeutic applications that target major conditions like chronic diseases. The growth prospects of several pharmaceuticals sectors of the healthcare industry are impacted by the rising healthcare expenditure. This will boost the adoption of protein expression products that are used in the detection of several chronic diseases like cardiovascular diseases and diabetes. The expenses involved in cell-free protein expression systems and the requirement of competent cells and reagents for protein expression are projected to hinder the growth of the market.

REGIONAL INSIGHTS

The global protein expression market is geographically segmented into Europe, Asia Pacific, North America, and the rest of the world. The North America region dominated the global market in 2019 with the largest revenue share, while the Asia Pacific is estimated to record growth at a steady pace, registering the highest CAGR by 2028. The growing aging population and the increasing awareness in terms of treatment options are the main factors that constitute the growth prospects of the North American region.

COMPETITIVE INSIGHTS

The market is deemed to have high scope for sustainable competition. Agilent Technologies Inc, Genscript Biotech Corporation, Lifesensors Inc, Becton, Dickinson And Company, Bio-Rad Laboratories Inc, etc. are some of the leading companies in the market.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING NUMBER OF CHRONIC DISEASE
    • 3.2.2. WORLDWIDE RISE IN HEALTHCARE EXPENDITURE
    • 3.2.3. INCREASING R&D IN THE FIELDS OF GENOMICS AND PROTEOMICS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. HIGH COST OF PROTEIN EXPRESSION SYSTEMS
    • 3.3.2. LACK OF EFFECTIVE SYSTEMS FOR POST-TRANSLATIONAL MODIFICATIONS

4. KEY ANALYTICS

  • 4.1. KEY INVESTMENT INSIGHTS
  • 4.2. PORTER'S FIVE FORCE ANALYSIS
    • 4.2.1. BUYER POWER
    • 4.2.2. SUPPLIER POWER
    • 4.2.3. SUBSTITUTION
    • 4.2.4. NEW ENTRANTS
    • 4.2.5. INDUSTRY RIVALRY
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE

5. MARKET BY PRODUCT TYPE

  • 5.1. REAGENTS
  • 5.2. EXPRESSION VECTORS
  • 5.3. COMPETENT CELLS
  • 5.4. INSTRUMENTS
  • 5.5. SERVICES

6. MARKET BY APPLICATION

  • 6.1. THERAPEUTIC
  • 6.2. INDUSTRIAL
  • 6.3. RESEARCH

7. MARKET BY END-USER

  • 7.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 7.2. ACADEMIC RESEARCH INSTITUTES
  • 7.3. CONTRACT RESEARCH ORGANIZATIONS
  • 7.4. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. UNITED KINGDOM
    • 8.2.2. GERMANY
    • 8.2.3. FRANCE
    • 8.2.4. ITALY
    • 8.2.5. RUSSIA
    • 8.2.6. BELGIUM
    • 8.2.7. POLAND
    • 8.2.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. CHINA
    • 8.3.2. JAPAN
    • 8.3.3. INDIA
    • 8.3.4. SOUTH KOREA
    • 8.3.5. INDONESIA
    • 8.3.6. THAILAND
    • 8.3.7. VIETNAM
    • 8.3.8. AUSTRALIA & NEW ZEALAND
    • 8.3.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST & AFRICA

9. COMPANY PROFILES

  • 9.1. AGILENT TECHNOLOGIES INC
  • 9.2. BECTON, DICKINSON AND COMPANY
  • 9.3. BIO-RAD LABORATORIES INC
  • 9.4. GENSCRIPT BIOTECH CORPORATION
  • 9.5. LIFESENSORS INC
  • 9.6. MERCK KGAA
  • 9.7. PROMEGA CORPORATION
  • 9.8. QIAGEN N.V.
  • 9.9. TAKARA HOLDINGS INC
  • 9.10. THERMO FISHER SCIENTIFIC INC
  • 9.11. LONZA INC
  • 9.12. NEW ENGLAND BIOLABS
  • 9.13. BIOTECHRABBIT GMBH
  • 9.14. PROMAB BIOTECHNOLOGIES GMBH
  • 9.15. PEAK PROTEINS LTD
Back to Top
전화 문의
F A Q